Search results
Results from the WOW.Com Content Network
Antiplatelet therapy with one or more of these drugs decreases the ability of blood clots to form by interfering with the platelet activation process in primary hemostasis. Antiplatelet drugs can reversibly or irreversibly inhibit the process involved in platelet activation resulting in decreased tendency of platelets to adhere to one another ...
Two main categories of antiplatelets are COX-1 inhibitors and ADP receptor inhibitors, while anticoagulants include vitamin K antagonists, direct oral anticoagulants (DOACs) and indirect thrombin inhibitors. Since cardiovascular agents have narrow therapeutic windows, a slight rise in dose may result in severe toxicity. Hence, monitoring at ...
An antithrombotic agent is a drug that reduces the formation of blood clots (). [1] [2] Antithrombotics can be used therapeutically for prevention (primary prevention, secondary prevention) or treatment of a dangerous blood clot (acute thrombus).
9 Antiplatelet drug. 10 Anticoagulant. 11 Fibrinolytics. 12 Diuretics. 13 References. Toggle the table of contents. List of cardiac pharmaceutical agents. Add ...
Anticoagulants (5 C, 31 P) Antiplatelet drugs (3 C, 16 P) Antithrombotic enzymes (14 P) F. Fibrinolytic enzymes (17 P) Pages in category "Antithrombotic agents"
antiplatelets, which prevent blood clots by affecting platelets beta-blockers , calcium channel blockers , and renin-angiotensin system-acting agents, which all help lower blood pressure.
An anticoagulant, commonly known as a blood thinner, is a chemical substance that prevents or reduces the coagulation of blood, prolonging the clotting time. [1] Some occur naturally in blood-eating animals, such as leeches and mosquitoes, which help keep the bite area unclotted long enough for the animal to obtain blood.
Pages in category "Antiplatelet drugs" The following 16 pages are in this category, out of 16 total. This list may not reflect recent changes. * Antiplatelet drug; A.